Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Liver Diseases

Free Subscription 13.07.2026 1 Am J Gastroenterol 1 Ann Intern Med 2 Biochem Biophys Res Commun 1 BMC Cancer 5 BMC Gastroenterol 1 Cancer Res 1 Endoscopy 1 Eur J Pediatr 2 Eur Radiol 1 Gut 1 Indian J Gastroenterol 2 J Gastroenterol Hepatol 5 J Hepatol 1 J Pediatr 1 Oncogene 2 PLoS One 2 Radiol Imaging Cancer 1 Radiologia (Engl Ed) 1 Radiology 1 Semin Liver Dis 1 Transplantation

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Gastroenterol

1. RUSSIN M, Moon A
   Designing and Interpreting Large Database Studies in GI and Hepatology.
   Am J Gastroenterol. 2026 Jul 9. doi: 10.14309/ajg.0000000000004110.
   PubMed        
   
   

   
   Ann Intern Med

2. SIMON TG, Zhang Y, Kehoe A, Chung RT, et al
   The Comparative Effectiveness of Carvedilol Versus Other Nonselective beta-Blockers in Cirrhosis.
   Ann Intern Med. 2026 Jul 7. doi: 10.7326/ANNALS-25-04010.
   PubMed         Abstract available
   
   

   
   Biochem Biophys Res Commun

3. HUANG LN, Zhang CH, Cheng G, Chen F, et al
   RPP40, a subunit of Ribonuclease P, facilitates hepatocellular carcinoma proliferation by activating the mTOR/MYC signaling.
   Biochem Biophys Res Commun. 2026;830:154246.
   PubMed         Abstract available
   
   
4. ZHANG Y, Huang H, Su Q, Zhou Y, et al
   Development and validation of HSP90AA1 as a risk gene in a HIF-1alpha pathway-related prognostic signature for hepatocellular carcinoma.
   Biochem Biophys Res Commun. 2026;830:154239.
   PubMed         Abstract available
   
   

   
   BMC Cancer

5. NI J, Sun H, Li C, Liu Y, et al
   Drug-eluting bead TACE improves the efficacy of HAIC combined with molecular-targeted therapy and anti-PD-1 immunotherapy in large hepatocellular carcinoma with inferior vena cava and/or right atrium tumor thrombus: a multicenter retrospective cohort
   BMC Cancer. 2026 Jul 6. doi: 10.1186/s12885-026-16497.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

6. HU Y, Zhang F, Zhang F, Xiang P, et al
   Association between metabolic syndrome and 90-day mortality in acute-on-chronic liver failure patients based on propensity score matching and prognostic model construction.
   BMC Gastroenterol. 2026;26:434.
   PubMed         Abstract available
   
   
7. ZHANG H, Jiang Z, Zheng H, Wang H, et al
   Liver CT-based composite biomarkers can identify MASH and steatosis grade in people with obesity prior to bariatric surgery: a retrospective study.
   BMC Gastroenterol. 2026;26:419.
   PubMed         Abstract available
   
   
8. JIAO J, Zhao R, Zhang Y, Xu M, et al
   Clinical value and safety of liver biopsy in patients with liver failure.
   BMC Gastroenterol. 2026;26:412.
   PubMed         Abstract available
   
   
9. SUI WF, Duan YX, Cai ZF, Li JY, et al
   Transarterial chemoembolization combined with tyrosine kinase inhibitors and programmed death-1 inhibitors in recurrent intermediate and advanced hepatocellular carcinoma: a single-centre retrospective cohort study.
   BMC Gastroenterol. 2026 Jul 9. doi: 10.1186/s12876-026-05070.
   PubMed         Abstract available
   
   
10. WANG JY, Zhang MX, Su SH, Tang SH, et al
    Etiology-related differences in hepatic recompensation in decompensated cirrhosis under Baveno VII criteria: a systematic review and meta-analysis.
    BMC Gastroenterol. 2026 Jul 8. doi: 10.1186/s12876-026-05087.
    PubMed         Abstract available
    
    

    
    Cancer Res

11. SUN T, Sun Q, Zhang X, Wang C, et al
    SEPTIN7 Enhances Tumorgenesis and Therapeutic Resistance in Hepatocellular Carcinoma by Promoting FGFR4 Stabilization and Recycling.
    Cancer Res. 2026 Jul 6. doi: 10.1158/0008-5472.CAN-25-5924.
    PubMed         Abstract available
    
    

    
    Endoscopy

12. KOKUBU M, Mori H, Yamamoto Y, Sato M, et al
    Novel anchor ring-shaped thread countertraction for colorectal endoscopic submucosal dissection beyond the hepatic flexure.
    Endoscopy. 2026 Jul 8. doi: 10.1055/a-2901-6505.
    PubMed        
    
    

    
    Eur J Pediatr

13. GROTRA R, Malik R, Abbey D
    Advancing precision hepatology for rare paediatric liver diseases.
    Eur J Pediatr. 2026;185:558.
    PubMed         Abstract available
    
    

    
    Eur Radiol

14. WASSENAAR NPM, van Son KC, Voermans B, van Eekhout KMA, et al
    Combination of quantitative MRI and laboratory markers for the detection and staging of metabolic dysfunction-associated steatotic liver disease.
    Eur Radiol. 2026;36:6523-6534.
    PubMed         Abstract available
    
    
15. ALI R, Li H, Reeder SB, Harris D, et al
    Development and validation of a deep learning model for liver shear stiffness regression using abdominal multiparametric MRI across multiple sites and vendors.
    Eur Radiol. 2026;36:6232-6245.
    PubMed         Abstract available
    
    

    
    Gut

16. DARUWALLA C, Calderon E, Mathew C, Mignogna L, et al
    Outcome scoring systems for locoregional therapy in hepatocellular carcinoma: a systematic review.
    Gut. 2026 Jul 9:gutjnl-2025-337557. doi: 10.1136/gutjnl-2025-337557.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

17. SAHOO B, Hembram J, Panigrahi MK, Mishra SK, et al
    Albumin-bilirubin grade and sarcopenia as predictors of prognosis in patients with unresectable intermediate and advanced-stage hepatocellular carcinoma.
    Indian J Gastroenterol. 2026 Jul 6. doi: 10.1007/s12664-026-02016.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

18. JEE Y, Lee SJ, Chun HS, Shin HY, et al
    Smoking and Risk of Hepatic Steatosis Within the MASLD Spectrum in Korean Young Adults.
    J Gastroenterol Hepatol. 2026 Jul 9. doi: 10.1111/jgh.70550.
    PubMed         Abstract available
    
    
19. CHE K, Lin K, Li S
    Comments on "Outcomes of Patients With Hepatocellular Carcinoma Treated With Durvalumab Plus Tremelimumab in Real-World Clinical Practice Who Met or Did Not Meet the Inclusion Criteria for the Phase 3 HIMALAYA Trial".
    J Gastroenterol Hepatol. 2026 Jul 7. doi: 10.1111/jgh.70558.
    PubMed        
    
    

    
    J Hepatol

20. GIUFFRE M, Kresevic S, Ravaioli F, Zykus R, et al
    Validation of a pan-ELastography Machine-learning (ELM) score to predict clinically significant portal hypertension in compensated advanced chronic liver disease.
    J Hepatol. 2026 Jul 8:S0168-8278(26)02681-4. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    
21. LING Q, Xie H, Lu D, Wei X, et al
    Retraction notice to "Association between donor and recipient TCF7L2 gene polymorphisms and the risk of new-onset diabetes mellitus after liver transplantation in a Han Chinese population" [J Hepatol 58 (2013) 271-277].
    J Hepatol. 2026 Jul 7:S0168-8278(26)02626-7. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
22. SANDMANN L
    Optimising the screening strategy for early-stage hepatocellular carcinoma.
    J Hepatol. 2026 Jul 6:S0168-8278(26)02647-4. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
23. MOLES A, Murphy L, Wilson CL, Chakraborty JB, et al
    Corrigendum to: "A TLR2/S100A9/CXCL-2 signaling network is necessary for neutrophil recruitment in acute and chronic liver injury in the mouse" [J Hepatol (2014) 60: 782-91].
    J Hepatol. 2026 Jul 6:S0168-8278(26)02649-8. doi: 10.1016/j.jhep.2026.
    PubMed        
    
    
24. PAPATHEODORIDIS GV, Dalekos G, Idilman R, Sypsa V, et al
    Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort.
    J Hepatol. 2026 Jul 6:S0168-8278(26)02702-9. doi: 10.1016/j.jhep.2026.
    PubMed         Abstract available
    
    

    
    J Pediatr

25. DERUYTER H, Aitokari L, Iqbal A, Eloranta AM, et al
    Perinatal and Lifestyle Factors Associated with Childhood Alanine Aminotransferase Levels as an Early Indicator of MASLD: A Population-Based Study.
    J Pediatr. 2026 May 12:115146. doi: 10.1016/j.jpeds.2026.115146.
    PubMed         Abstract available
    
    

    
    Oncogene

26. DU Y, Zhang XF, Wu S, Zheng J, et al
    PTP4A3 dephosphorylates EGFR to promote metastasis and enhance sensitivity to lapatinib in hepatocellular carcinoma.
    Oncogene. 2026 Jul 8. doi: 10.1038/s41388-026-03866.
    PubMed         Abstract available
    
    

    
    PLoS One

27. NASIR AB, Kilani Y, Aldiabat M, Abdelghany O, et al
    Metabolic risk and metabolic dysfunction-associated steatotic liver disease and steatohepatitis in cognitive decline: A retrospective cohort study.
    PLoS One. 2026;21:e0353160.
    PubMed         Abstract available
    
    
28. STEUP C, Mondorf A, Wild P, Pession U, et al
    Higher frequency of subclonal anti-EGFR resistance mutations in post-treatment samples from patients with colorectal cancer liver metastases following anti-EGFR-based conversion chemotherapy.
    PLoS One. 2026;21:e0351243.
    PubMed         Abstract available
    
    

    
    Radiol Imaging Cancer

29. NARDONE L, Ocal E, Salvermoser L, Fabritius MP, et al
    Cross-Cancer Circulating Proteins for the Prognosis of Primary and Metastatic Liver Cancer Treated with Local Ablation: Post Hoc Exploratory Analysis of the ESTIMATE Trial.
    Radiol Imaging Cancer. 2026;8:e250685.
    PubMed         Abstract available
    
    
30. WANG K, Xie C, Wu M, Kang S, et al
    Deciphering Colorectal Liver Metastasis Perfusion Heterogeneity: Identification of Distinct Vascular Phenotypes through High-Lateral-Resolution Photoacoustic Microscopy.
    Radiol Imaging Cancer. 2026;8:e250523.
    PubMed         Abstract available
    
    

    
    Radiologia (Engl Ed)

31. IGUAL ROUILLEAULT AC, Jimenez S, Moreno J, Belmonte E, et al
    Imaging findings of hepatic storage diseases.
    Radiologia (Engl Ed). 2026;68:101670.
    PubMed         Abstract available
    
    

    
    Radiology

32. JEON SK, Joo I, Kang HJ, Kim JH, et al
    Noncontrast Abbreviated MRI for Post-TACE Treatment Response Monitoring of Hepatocellular Carcinoma Based on Ancillary Features from LI-RADS.
    Radiology. 2026;320:e252803.
    PubMed         Abstract available
    
    

    
    Semin Liver Dis

33. CARTEE BS, Diniz F, Rai R, Pal PB, et al
    Hepatosystemic T cell licensing in MASLD-associated neuroinflammation.
    Semin Liver Dis. 2026 Jul 6. doi: 10.1055/a-2908-1230.
    PubMed         Abstract available
    
    

    
    Transplantation

34. CHOI HH, Choi Y, Kim JY, Kim J, et al
    Hepatic Congestion-linked Intrahepatic Biliary Strictures After Living Donor Liver Transplantation.
    Transplantation. 2026 Apr 27. doi: 10.1097/TP.0000000000005730.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum